142 related articles for article (PubMed ID: 11879758)
1. Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions.
Watnasirichaikul S; Rades T; Tucker IG; Davies NM
Int J Pharm; 2002 Mar; 235(1-2):237-46. PubMed ID: 11879758
[TBL] [Abstract][Full Text] [Related]
2. In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion.
Watnasirichaikul S; Rades T; Tucker IG; Davies NM
J Pharm Pharmacol; 2002 Apr; 54(4):473-80. PubMed ID: 11999123
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the entrapment of hydrophilic compounds in nanocapsules prepared by interfacial polymerisation of water-in-oil microemulsions.
Pitaksuteepong T; Davies NM; Tucker IG; Rades T
Eur J Pharm Biopharm; 2002 May; 53(3):335-42. PubMed ID: 11976022
[TBL] [Abstract][Full Text] [Related]
4. The stability and controlled release of I-ascorbic acid encapsulated in poly (ethyl-2-cyanoacrylate) nanocapsules prepared by interfacial polymerization of water-in-oil microemulsions.
Zhang SN; Chen T; Guo YG; Zhang J; Song X; Zhou L
J Cosmet Sci; 2015; 66(4):247-59. PubMed ID: 26665980
[TBL] [Abstract][Full Text] [Related]
5. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions.
Watnasirichaikul S; Davies NM; Rades T; Tucker IG
Pharm Res; 2000 Jun; 17(6):684-9. PubMed ID: 10955841
[TBL] [Abstract][Full Text] [Related]
6. Protein delivery using nanoparticles based on microemulsions with different structure-types.
Graf A; Jack KS; Whittaker AK; Hook SM; Rades T
Eur J Pharm Sci; 2008 Apr; 33(4-5):434-44. PubMed ID: 18329862
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs.
Fresta M; Cavallaro G; Giammona G; Wehrli E; Puglisi G
Biomaterials; 1996 Apr; 17(8):751-8. PubMed ID: 8730958
[TBL] [Abstract][Full Text] [Related]
8. Increasing entrapment of peptides within poly(alkyl cyanoacrylate) nanoparticles prepared from water-in-oil microemulsions by copolymerization.
Liang M; Davies NM; Toth I
Int J Pharm; 2008 Oct; 362(1-2):141-6. PubMed ID: 18598746
[TBL] [Abstract][Full Text] [Related]
9. Poly(alkylcyanoacrylate) nanocapsules: physicochemical characterization and mechanism of formation.
Chouinard F; Buczkowski S; Lenaerts V
Pharm Res; 1994 Jun; 11(6):869-74. PubMed ID: 7937528
[TBL] [Abstract][Full Text] [Related]
10. Polyalkyl cyanoacrylate nanocapsules.
el-Samaligy MS; Rohdewald P; Mahmoud HA
J Pharm Pharmacol; 1986 Mar; 38(3):216-8. PubMed ID: 2871158
[TBL] [Abstract][Full Text] [Related]
11. Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization.
Krauel K; Davies NM; Hook S; Rades T
J Control Release; 2005 Aug; 106(1-2):76-87. PubMed ID: 15967536
[TBL] [Abstract][Full Text] [Related]
12. Photo-oxidative action in MCF-7 cancer cells induced by hydrophobic cyanines loaded in biodegradable microemulsion-templated nanocapsules.
Wilk KA; Zielińska K; Pietkiewicz J; Skołucka N; Choromańska A; Rossowska J; Garbiec A; Saczko J
Int J Oncol; 2012 Jul; 41(1):105-16. PubMed ID: 22552322
[TBL] [Abstract][Full Text] [Related]
13. Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules.
Cournarie F; Chéron M; Besnard M; Vauthier C
Eur J Pharm Biopharm; 2004 Mar; 57(2):171-9. PubMed ID: 15018972
[TBL] [Abstract][Full Text] [Related]
14. Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides.
Graf A; Ablinger E; Peters S; Zimmer A; Hook S; Rades T
Int J Pharm; 2008 Feb; 350(1-2):351-60. PubMed ID: 17923347
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical and morphological characterization of polyisobutyl cyanoacrylate nanocapsules.
Rollot JM; Couvreur P; Roblot-Treupel L; Puisieux F
J Pharm Sci; 1986 Apr; 75(4):361-4. PubMed ID: 3723356
[TBL] [Abstract][Full Text] [Related]
16. Monosize poly(ethylcyanoacrylate) microspheres: preparation and degradation properties.
Tuncel A; Ciçek H; Hayran M; Pişkin E
J Biomed Mater Res; 1995 Jun; 29(6):721-8. PubMed ID: 7593009
[TBL] [Abstract][Full Text] [Related]
17. Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue.
Damgé C; Vonderscher J; Marbach P; Pinget M
J Pharm Pharmacol; 1997 Oct; 49(10):949-54. PubMed ID: 9364401
[TBL] [Abstract][Full Text] [Related]
18. Effects of external phase on D-cycloserine loaded W/O nanocapsules prepared by the interfacial polymerization method.
Musumeci T; Ventura CA; Carbone C; Pignatello R; Puglisi G
Eur J Med Chem; 2011 Jul; 46(7):2828-34. PubMed ID: 21530017
[TBL] [Abstract][Full Text] [Related]
19. Permeability profile of poly(alkyl cyanoacrylate) nanocapsules.
Erdmann C; Mayer C
J Colloid Interface Sci; 2016 Sep; 478():394-401. PubMed ID: 27343463
[TBL] [Abstract][Full Text] [Related]
20. Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin.
Damgé C; Vranckx H; Balschmidt P; Couvreur P
J Pharm Sci; 1997 Dec; 86(12):1403-9. PubMed ID: 9423155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
